The therapy of chronic myeloid leukemia with Gleevec (Imatinib mesylate) began to be used in patients in 2001 and seemed to be real success. Since that time, a clinical study revealed the efficiency of Gleevec in other cancer types as well such as in hypereosinophilic syndrome, another blood cancer.
The therapy of chronic myeloid leukemia with […]

